|
Outcomes
|
Group
|
Baseline
|
Between groups at 6 weeks A)
|
Within groups (6 weeks–baseline) B)
|
|---|
| | |
Mean (SD)
|
Mean (SD)
|
Diff. (95% CI)
| |
Diff (95% CI)
|
p-value
|
|---|
|
TAS
|
INT
| |
5.01 (0.8)
|
0.32 (−0.11, 0.75)
|
0.137
| | |
|
CTRL
| |
4.69 (0.8)
| | | | |
|
CSQ
|
INT
| |
25.59 (4.0)
|
1.16 (−0.84, 3.16)
|
0.248
| | |
|
CTRL
| |
24.43 (3.6)
| | | | |
|
BASIS-32
†
|
INT
|
1.10 (0.5)
|
1.03 (0.5)
|
0.04 (−0.22, 0.30)
| |
−0.07 (−0.27, 0.14)
|
0.515
|
|
CTRL
|
1.27 (0.6)
|
1.09 (0.6)
| |
0.766
|
−0.18 (−0.37, 0.01)
|
0.069
|
|
PAM
|
INT
|
35.17 (6.4)
|
39.43 (7.0)
|
2.53 (−2.04, 7.10)
|
0.272
|
4.26 (1.71, 6.81)*
|
0.002
|
|
CTRL
|
36.17 (8.8)
|
37.29 (10.5)
| | |
1.12 (−3.15, 5.40)
|
0.596
|
|
MCS (SF-12)
|
INT
|
37.41 (7.5)
|
39.94 (7.8)
|
−0.29 (−4.21, 3.63)
|
0.883
|
2.54 (−0.40, 5.48)
|
0.088
|
|
CTRL
|
37.37 (6.1)
|
40.21 (8.5)
| | |
2.84 (−0.23, 5.92)
|
0.069
|
|
PCS (SF-12)
|
INT
|
47.46 (8.4)
|
48.84 (9.9)
|
1.42 (−2.20, 5.04)
|
0.434
|
1.38 (−1.48, 4.24)
|
0.330
|
|
CTRL
|
48.09 (8.6)
|
47.90 (9.0)
| | |
−0.18 (−2.70, 2.34)
|
0.883
|
|
ORS
|
INT
|
17.55 (7.0)
|
22.07 (9.0)
|
2.68 (−1.74, 7.09)
|
0.229
|
4.52 (1.31, 7.73)*
|
0.008
|
|
CTRL
|
16.16 (7.0)
|
18.63 (9.2)
| | |
2.47 (−0.94, 5.89)
|
0.150
|
|
SRS
|
INT
| |
34.68 (5.6)
|
3.15 (0.07, 6.37)
|
0.055
| | |
|
CTRL
| |
31.53 (6.4)
| | | | |
|
PM
|
INT
|
5.38 (0.8)
|
5.65 (0.5)
|
0.28 (0.04, 0.42)
|
0.024
|
0.27 (−0.04, 0.57)
|
0.081
|
|
CTRL
|
5.32 (0.9)
|
5.34 (0.7)
| | |
0.02 (−0.14, 0.19)
|
0.788
|
|
PP
|
INT
| |
4.73 (0.7)
|
0.07 (−0.29, 0.42)
|
0.706
| | |
| |
CTRL
| |
4.66 (0.6)
| | | | |
- Comparison of outcomes between the intervention group (INT, n = 26) and control group (CTRL, n = 32) six weeks after treatment start, and within each group from baseline to six weeks.
- TAS = Treatment alliance score, CSQ = Client satisfaction questionnaire, BASIS-32 = The behavior and symptom identification scale 32, PAM = Patient activation measure, MCS (SF-12) = Mental Component Score (Short form-12), PCS (SF-12) = Physical Component Score (Short form-12), ORS = Outcome rating scale, SRS = Session rating scale, PM = Patient motivation, PP = Patient participation.
- A) The between-group mean differences for TAS, CSQ, SRS and PP have been calculated using two-tailed independent t-tests. The between-group estimated mean differences for BASIS-32, PAM, SF12, ORS, and PM have been calculated using analysis of covariance (ANCOVA), adjusted for baseline values.
- B) The within group differences have been calculated using two-tailed paired t-test.
-
† Decrease in score indicates improvement (less mental health symptoms) for BASIS-32. For the other outcomes, increased score indicates improvement.
- * p-value ≤0.05.
